NCT00243880View on ClinicalTrials.gov

Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START)

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Stroke
Interventions
DRUG

lovastatin

investigators will treat the patients within 24 hours of symptom onset with short term high-dose lovastatin at escalating dosage. The escalating dosage levels will be 1, 3, 6, 8, and 10 mg/kg per day for 3 days.

Trial Locations (1)

10032

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER

NCT00243880 - Neuroprotection With Statin Therapy for Acute Recovery Trial (Neu-START) | Biotech Hunter | Biotech Hunter